Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02019121 · ClinicalTrials.gov registry record
Dexmedetomidine and Renal Transplants
A clinical trial, sponsored by University of California, Davis.
- Completed
- Registry status
- 797
- Enrollment target
NCT02019121 is a clinical trial that has completed, run by University of California, Davis. The registered enrollment target is 797 participants.
The verdict
NCT02019121 has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- 797 participants
- Enrollment target
Study Summary
Investigators aim to retrospectively research patients undergoing renal transplants that received dexmedetomidine perioperatively to see if dexmedetomidine use protects renal function. Investigators hope to elucidate any association between renal transplant patients and perioperative dexmedetomidine administration, these include (but are not limited to) UOP, Cr/GFR, morbidity, mortality, in hospital complications and failure rate. Investigators will research both living and cadaveric renal transplants.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 797 participants |
| Start Date | 2013-10 |
| Est. Completion | 2020-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02019121
The ClinicalTrials.gov registry entry for NCT02019121 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 797 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02019121 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02019121 about?
NCT02019121 is a clinical study titled "Dexmedetomidine and Renal Transplants". Investigators aim to retrospectively research patients undergoing renal transplants that received dexmedetomidine perioperatively to see if dexmedetomidine use protects renal function. Investigators hope to elucidate any association between renal transplant patients and perioperative dexmedetomidine...
What is the current status of trial NCT02019121?
This trial is currently completed. The enrollment target is 797 participants. The study started on 2013-10. Estimated completion is 2020-02.
Who is sponsoring clinical trial NCT02019121?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.